跳至主要内容
临床试验/TCTR20180724002
TCTR20180724002已完成4 期

Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End Stage Renal Disease: a Randomized Crossover Study

Phramongkutklao Hospital and College of Medicine0 个研究点目标入组 51 人开始时间: 2018年7月24日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
51

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • Inclusion criteria comprised being 18 years or older, diagnosis of T2DM, on hemodialysis three sessions weekly and for at least three months, stable insulin dosage for at least three months and stable glycemic treatment with HbA1c<8% for at least three months

排除标准

  • Exclusion criteria included diagnosis of type 1 diabetes, pregnancy, active malignancy, being physically-challenged, active or chronic infection within three months of starting the study and symptomatic hypo- or hyperglycemia within three months.

研究者

发起方
Phramongkutklao Hospital and College of Medicine

相似试验